For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
In this article:
In-line sales for Alzheimer’s drug Leqembi and a beat for rare-disease drug Skyclarys has Wall Street giving Biogen another chance.
Advertisement
Recommended Stories
Apple, Rivian Reportedly In Talks For Partnership
Apple and EV maker Rivian are in talks for some form of partnership, DigiTimes reported. The Dow giant scrapped its Apple Car effort in February.
Investor's Business DailyThe Federal Reserve Just Indicated Social Security Could Get a Bigger 2025 Cost-of-Living Adjustment (COLA) Than Expected
A bigger COLA may sound great, but it has some big drawbacks for retirees too.
Motley FoolDow Jones Futures Fall: AI Stock Palantir Plunges On Earnings; Apple 'Let Loose' Event Next
Dow Jones Futures: AI stock leader Palantir plunged on earnings late Monday, while Apple's "Let Loose" event will take place Tuesday.
Investor's Business Daily3 Dividend-Paying Energy Stocks to Buy Hand Over Fist in May
With energy prices on the rise, here are three dividend stocks to consider in the energy sector, from high risk to low risk.
Motley FoolInstead of Buying Nvidia Stock, I'm Buying This AI ETF Hand Over Fist
Generative AI is generating big interest among investors, and this ETF provides plenty of industry exposure.
Motley FoolSeeking at Least 8% Dividend Yield? Analysts Offer 2 Dividend Stocks to Buy
The last inflation report, which came in worse than expected, had investors worried about the Federal Reserve’s plans for interest rates this year. The central bank held rates steady in its most recent decision, cooling fears that a hike is in the offing. When combined with moderate gains in the Q1 earnings reports, it makes sense that we saw stocks rebounding as confidence in the market was restored. However, according to JPMorgan’s chief market strategist Marko Kolanovic, we’re not out of the
TipRanksBuy stocks in May because inflation is set to plunge through the rest of 2024, Fundstrat's Tom Lee says
Inflation is set for a dramatic decline that will pave the way for Fed rate cuts, Fundstrat's Tom Lee said.
Business InsiderGE Stock Soars 110% To A 15-Year High — Is GE Aerospace A Buy?
General Electric officially split into GE Aerospace and GE Vernova in April. GE Aerospace now trades at its best level since the 2008 meltdown.
Investor's Business DailyAnalysts brew up new Starbucks stock price targets after earnings
Here's what could happen next to Starbucks shares.
TheStreetLucid stock down on Q1 loss, confirms Gravity SUV on track for 'late 2024' launch
EV maker Lucid reported mixed first quarter results as a wider-than-expected loss trumped the company's confirmation that its Gravity SUV is still on track for a 2024 debut.
Yahoo Finance